Dr Felecia N Sumner, DO | |
85 N Lansdowne Ave Ste 4, Lansdowne, PA 19050-2073 | |
(215) 876-0360 | |
(667) 239-6162 |
Full Name | Dr Felecia N Sumner |
---|---|
Gender | Female |
Speciality | Family Medicine |
Location | 85 N Lansdowne Ave Ste 4, Lansdowne, Pennsylvania |
Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1831485796 | NPI | - | NPPES |
Mailing Address | Practice Location Address |
---|---|
Dr Felecia N Sumner, DO 85 N Lansdowne Ave Ste 4, Lansdowne, PA 19050-2073 Ph: (215) 876-0360 | Dr Felecia N Sumner, DO 85 N Lansdowne Ave Ste 4, Lansdowne, PA 19050-2073 Ph: (215) 876-0360 |
News Archive
Teledyne DALSA, a Teledyne Technologies company and global leader in digital X-Ray image sensing technology, will display its Xineos family of CMOS dynamic flat X-Ray detectors at the RSNA 2016 Technical Exhibition, November 27 to December 2, at McCormick Place in Chicago.
Researchers from the Department of Biomedical Research of the University of Bern and the University Clinic of Visceral Surgery and Medicine of the Inselspital Bern, Switzerland, have discovered that changes in the composition of the intestinal bacteria in patients with chronic inflammatory bowel disease affect the severity of the disease and the success of therapy.
American Indians living on reservations are at high risk for being exposed to such trauma as witnessing a loved one's death or being the victim of a physical attack, according to research comparing trauma on two American Indian reservations to that in the general U.S. population.
Cegedim Dendrite, the world's leading provider of pharmaceutical-specific Customer Relationship Management solutions, and Capgemini U.S. LLC ("Capgemini"), one of the world's foremost providers of consulting, technology and outsourcing services, announced an alliance to jointly offer software solutions, consulting and technology services around aggregate spend and customer master data to Life Sciences companies. Through the alliance, Capgemini will provide broad based consulting and implementation services associated with Cegedim Dendrite's AggregateSpend360™ and Nucleus 360™ solutions to pharmaceutical, biotech and medical device companies.
Researchers have found a genotype that could help identify sickle cell disease (SCD) patients at greatest risk of common, yet severe, complications of SCD.
› Verified 9 days ago